HEADER TRANSFERASE/INHIBITOR 15-MAR-17 5V61 TITLE PHOSPHO-ERK2 BOUND TO BIVALENT INHIBITOR SBP2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 8-367; COMPND 5 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2, COMPND 6 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2, COMPND 7 MAPK 2; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: RIBOSOMAL PROTEIN S6 KINASE ALPHA-1,PROTEIN TAT; COMPND 12 CHAIN: I; COMPND 13 FRAGMENT: UNP Q15418 RESIDUES 713-729, UNP P04608 RESIDUES 730-738; COMPND 14 SYNONYM: S6K-ALPHA-1,90 KDA RIBOSOMAL PROTEIN S6 KINASE 1,P90S6K,MAP COMPND 15 KINASE-ACTIVATED PROTEIN KINASE 1A,MAPKAPK-1A,RIBOSOMAL S6 KINASE 1, COMPND 16 RSK-1,TRANSACTIVATING REGULATORY PROTEIN; COMPND 17 EC: 2.7.11.1; COMPND 18 ENGINEERED: YES; COMPND 19 OTHER_DETAILS: RSK1 PEPTIDE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS, HIV-1 M:B_HXB2R; SOURCE 11 ORGANISM_COMMON: HUMAN, HIV-1; SOURCE 12 ORGANISM_TAXID: 9606, 11706 KEYWDS KINASE, MAPK, PHOSPHORYLATION, CANCER, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.C.LECHTENBERG,S.J.RIEDL REVDAT 6 15-NOV-23 5V61 1 REMARK REVDAT 5 04-OCT-23 5V61 1 REMARK REVDAT 4 04-DEC-19 5V61 1 REMARK REVDAT 3 18-APR-18 5V61 1 JRNL REVDAT 2 13-SEP-17 5V61 1 REMARK REVDAT 1 26-JUL-17 5V61 0 JRNL AUTH B.C.LECHTENBERG,P.D.MACE,E.H.SESSIONS,R.WILLIAMSON, JRNL AUTH 2 R.STALDER,Y.WALLEZ,G.P.ROTH,S.J.RIEDL,E.B.PASQUALE JRNL TITL STRUCTURE-GUIDED STRATEGY FOR THE DEVELOPMENT OF POTENT JRNL TITL 2 BIVALENT ERK INHIBITORS. JRNL REF ACS MED CHEM LETT V. 8 726 2017 JRNL REFN ISSN 1948-5875 JRNL PMID 28740606 JRNL DOI 10.1021/ACSMEDCHEMLETT.7B00127 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 25051 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1371 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3002 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 92 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.22000 REMARK 3 B22 (A**2) : 0.54000 REMARK 3 B33 (A**2) : 0.68000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.201 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.170 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.147 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.483 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 5V61 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1000226918. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-APR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26480 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 19.820 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 13.60 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.90 REMARK 200 R MERGE FOR SHELL (I) : 1.56900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2ERK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 6.5, 45% V/V REMARK 280 POLYPROPYLENE GLYCOL P400, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.10850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.09350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.16400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 76.09350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.10850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.16400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 5 REMARK 465 PRO A 6 REMARK 465 GLY A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 9 REMARK 465 SER A 360 REMARK 465 ARG I 728 REMARK 465 LYS I 729 REMARK 465 ARG I 730 REMARK 465 LYS I 731 REMARK 465 LYS I 732 REMARK 465 ARG I 733 REMARK 465 ARG I 734 REMARK 465 GLN I 735 REMARK 465 ARG I 736 REMARK 465 ARG I 737 REMARK 465 ARG I 738 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 149 36.84 -156.76 REMARK 500 ASP A 167 74.38 71.76 REMARK 500 ALA A 189 165.25 68.11 REMARK 500 ASN A 201 58.81 -144.41 REMARK 500 LEU A 294 45.53 -93.50 REMARK 500 LEU A 294 45.53 -98.44 REMARK 500 ALA I 712 175.60 66.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 LIGAND 90A LINKS FRZ AND INHIBITOR RSK1 PEPTIDE TO FORM BIVALENT REMARK 600 ERK INHIBITOR SBP2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues FRZ I 801 and 90A I REMARK 800 802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5V60 RELATED DB: PDB REMARK 900 RELATED ID: 5V62 RELATED DB: PDB DBREF 5V61 A 8 360 UNP P28482 MK01_HUMAN 8 360 DBREF 5V61 I 713 729 UNP Q15418 KS6A1_HUMAN 713 729 DBREF 5V61 I 730 738 UNP P04608 TAT_HV1H2 49 57 SEQADV 5V61 GLY A 5 UNP P28482 EXPRESSION TAG SEQADV 5V61 PRO A 6 UNP P28482 EXPRESSION TAG SEQADV 5V61 GLY A 7 UNP P28482 EXPRESSION TAG SEQADV 5V61 THR I 711 UNP Q15418 EXPRESSION TAG SEQADV 5V61 ALA I 712 UNP Q15418 EXPRESSION TAG SEQRES 1 A 356 GLY PRO GLY GLY ALA GLY PRO GLU MET VAL ARG GLY GLN SEQRES 2 A 356 VAL PHE ASP VAL GLY PRO ARG TYR THR ASN LEU SER TYR SEQRES 3 A 356 ILE GLY GLU GLY ALA TYR GLY MET VAL CYS SER ALA TYR SEQRES 4 A 356 ASP ASN VAL ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SEQRES 5 A 356 SER PRO PHE GLU HIS GLN THR TYR CYS GLN ARG THR LEU SEQRES 6 A 356 ARG GLU ILE LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN SEQRES 7 A 356 ILE ILE GLY ILE ASN ASP ILE ILE ARG ALA PRO THR ILE SEQRES 8 A 356 GLU GLN MET LYS ASP VAL TYR ILE VAL GLN ASP LEU MET SEQRES 9 A 356 GLU THR ASP LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SEQRES 10 A 356 SER ASN ASP HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU SEQRES 11 A 356 ARG GLY LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS SEQRES 12 A 356 ARG ASP LEU LYS PRO SER ASN LEU LEU LEU ASN THR THR SEQRES 13 A 356 CYS ASP LEU LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL SEQRES 14 A 356 ALA ASP PRO ASP HIS ASP HIS THR GLY PHE LEU TPO GLU SEQRES 15 A 356 PTR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET SEQRES 16 A 356 LEU ASN SER LYS GLY TYR THR LYS SER ILE ASP ILE TRP SEQRES 17 A 356 SER VAL GLY CYS ILE LEU ALA GLU MET LEU SER ASN ARG SEQRES 18 A 356 PRO ILE PHE PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN SEQRES 19 A 356 HIS ILE LEU GLY ILE LEU GLY SER PRO SER GLN GLU ASP SEQRES 20 A 356 LEU ASN CYS ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU SEQRES 21 A 356 LEU SER LEU PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG SEQRES 22 A 356 LEU PHE PRO ASN ALA ASP SER LYS ALA LEU ASP LEU LEU SEQRES 23 A 356 ASP LYS MET LEU THR PHE ASN PRO HIS LYS ARG ILE GLU SEQRES 24 A 356 VAL GLU GLN ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR SEQRES 25 A 356 TYR ASP PRO SER ASP GLU PRO ILE ALA GLU ALA PRO PHE SEQRES 26 A 356 LYS PHE ASP MET GLU LEU ASP ASP LEU PRO LYS GLU LYS SEQRES 27 A 356 LEU LYS GLU LEU ILE PHE GLU GLU THR ALA ARG PHE GLN SEQRES 28 A 356 PRO GLY TYR ARG SER SEQRES 1 I 28 THR ALA GLN LEU LYS PRO ILE GLU SER SER ILE LEU ALA SEQRES 2 I 28 GLN ARG ARG VAL ARG LYS ARG LYS LYS ARG ARG GLN ARG SEQRES 3 I 28 ARG ARG MODRES 5V61 TPO A 185 THR MODIFIED RESIDUE MODRES 5V61 PTR A 187 TYR MODIFIED RESIDUE HET TPO A 185 11 HET PTR A 187 16 HET GOL A 401 6 HET GOL A 402 6 HET GOL A 403 6 HET FRZ I 801 25 HET 90A I 802 20 HETNAM TPO PHOSPHOTHREONINE HETNAM PTR O-PHOSPHOTYROSINE HETNAM GOL GLYCEROL HETNAM FRZ 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3, HETNAM 2 FRZ 4-C]PYRIDAZIN-3-AMINE HETNAM 90A 2-OXO-6,9,12,15-TETRAOXA-3-AZAOCTADECAN-18-OIC ACID HETSYN TPO PHOSPHONOTHREONINE HETSYN PTR PHOSPHONOTYROSINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN FRZ FR180204 FORMUL 1 TPO C4 H10 N O6 P FORMUL 1 PTR C9 H12 N O6 P FORMUL 3 GOL 3(C3 H8 O3) FORMUL 6 FRZ C18 H13 N7 FORMUL 7 90A C13 H25 N O7 FORMUL 8 HOH *92(H2 O) HELIX 1 AA1 HIS A 61 PHE A 78 1 18 HELIX 2 AA2 THR A 94 MET A 98 5 5 HELIX 3 AA3 LEU A 112 GLN A 119 1 8 HELIX 4 AA4 SER A 122 ALA A 143 1 22 HELIX 5 AA5 LYS A 151 SER A 153 5 3 HELIX 6 AA6 THR A 190 ARG A 194 5 5 HELIX 7 AA7 ALA A 195 ASN A 201 1 7 HELIX 8 AA8 LYS A 207 ASN A 224 1 18 HELIX 9 AA9 HIS A 232 GLY A 245 1 14 HELIX 10 AB1 SER A 248 CYS A 254 1 7 HELIX 11 AB2 ASN A 257 LEU A 267 1 11 HELIX 12 AB3 PRO A 274 PHE A 279 1 6 HELIX 13 AB4 ASP A 283 LEU A 294 1 12 HELIX 14 AB5 ASN A 297 ARG A 301 5 5 HELIX 15 AB6 GLU A 303 HIS A 310 1 8 HELIX 16 AB7 PRO A 311 GLU A 314 5 4 HELIX 17 AB8 ASP A 318 GLU A 322 5 5 HELIX 18 AB9 LYS A 330 LEU A 335 5 6 HELIX 19 AC1 PRO A 339 ALA A 352 1 14 HELIX 20 AC2 ARG A 353 GLN A 355 5 3 HELIX 21 AC3 SER I 720 ARG I 726 1 7 SHEET 1 AA1 2 MET A 13 VAL A 14 0 SHEET 2 AA1 2 GLN A 17 VAL A 18 -1 O GLN A 17 N VAL A 14 SHEET 1 AA2 5 TYR A 25 GLY A 34 0 SHEET 2 AA2 5 GLY A 37 ASP A 44 -1 O SER A 41 N SER A 29 SHEET 3 AA2 5 VAL A 49 ILE A 56 -1 O LYS A 55 N MET A 38 SHEET 4 AA2 5 VAL A 101 ASP A 106 -1 O GLN A 105 N ALA A 52 SHEET 5 AA2 5 ASP A 88 ILE A 90 -1 N ILE A 90 O TYR A 102 SHEET 1 AA3 3 THR A 110 ASP A 111 0 SHEET 2 AA3 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 AA3 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 AA4 2 VAL A 145 LEU A 146 0 SHEET 2 AA4 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 LINK C LEU A 184 N TPO A 185 1555 1555 1.33 LINK C TPO A 185 N GLU A 186 1555 1555 1.33 LINK C GLU A 186 N PTR A 187 1555 1555 1.33 LINK C PTR A 187 N VAL A 188 1555 1555 1.33 LINK N THR I 711 C15 90A I 802 1555 1555 1.35 LINK N29 FRZ I 801 C6 90A I 802 1555 1555 1.43 CISPEP 1 GLY A 22 PRO A 23 0 2.44 CISPEP 2 GLN A 355 PRO A 356 0 0.48 SITE 1 AC1 1 LEU A 234 SITE 1 AC2 3 PRO A 319 SER A 320 HOH A 559 SITE 1 AC3 3 ASP A 179 PHE A 183 PHE A 331 SITE 1 AC4 16 TYR A 36 ALA A 52 LYS A 54 ILE A 103 SITE 2 AC4 16 GLN A 105 ASP A 106 LEU A 107 MET A 108 SITE 3 AC4 16 GLU A 109 LYS A 114 ASN A 154 LEU A 156 SITE 4 AC4 16 ASP A 167 GLY A 357 TYR A 358 ARG A 359 CRYST1 42.217 78.328 152.187 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023687 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012767 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006571 0.00000